Yıl: 2021 Cilt: 30 Sayı: 1 Sayfa Aralığı: 70 - 76 Metin Dili: İngilizce DOI: 10.9739/tjvs.2021.748 İndeks Tarihi: 16-06-2022

How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered

Öz:
In December 2019, a serious number of patients with pneumonia was first announced in Wuhan and, since March 11, 2020, the World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-2019) caused by SARS-CoV-2 to be a pandemic and a very severe global health problem. Severity about this disease is associated with an increasing age and comorbidities such as chronic heart and lung disease. Chronic thromboembolic pulmonary hypertension (CTEPH), another important and fatal disease, is a specific type of pulmonary hypertension characterized by obstruction or occlusion of subsegmental, segmental, or larger pulmonary arteries by the post-embolic fibrotic material which has a definitive cure by pulmonary endarterectomy performed under cardiopulmonary bypass and total circulatory arrest. In this article, we examined thoroughly and enlightened some of the gray zones in CTEPH patients for healthcare providers with the aim of providing a reasonable algorithm in the era of COVID-19 pandemic.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
0
0
0
  • 1. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020. [Epub ahead of print]
  • 2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
  • 3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33.
  • 4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020:e201585.
  • 5. Chen X, Liu Y, Gong Y, Guo X, Zuo M, Li J, et al. Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. Anesthesiology 2020. [Epub ahead of print]
  • 6. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119.
  • 7. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019;54:1901647.
  • 8. Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation 2014;130:508-18.
  • 9. Grech V. Unknown unknowns - COVID-19 and potential global mortality. Early Hum Dev 2020;144:105026.
  • 10. Neskovic AN, Skinner H, Price S, Via G, De Hert S, Stankovic I, et al. Focus cardiac ultrasound core curriculum and core syllabus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2018;19:475-81.
  • 11. Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost 2020. [Epub ahead of print]
  • 12. Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012;94:97-103.
  • 13. Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg 2006;82:2139-45.
  • 14. Levy JH, Tanaka KA. Inf lammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-20.
  • 15. Royster RL, Grosshans DW, Kon ND. A multimodal approach to address the inflammation of cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2011;25:e35.
  • 16. Appoo JJ, Augoustides JG, Pochettino A, Savino JS, McGarvey ML, Cowie DC, et al. Perioperative outcome in adults undergoing elective deep hypothermic circulatory arrest with retrograde cerebral perfusion in proximal aortic arch repair: evaluation of protocol-based care. J Cardiothorac Vasc Anesth 2006;20:3-7.
  • 17. Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global view of pulmonary hypertension. Lancet Respir Med 2016;4:306-22.
  • 18. Simonneau G, D’Armini AM, Ghofrani HA, Grimminger F, Jansa P, Kim NH, et al. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. Lancet Respir Med 2016;4:372-80.
  • 19. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269-71.
  • 20. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
  • 21. Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 2005;45:127-32.
APA AKAY T, Sade L, Savas Bozbas S, Hekimoglu K, okyay k, Gultekin B, BEYAZPINAR D, GUNERTEM E, Aliyev A, Sezgin A (2021). How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . , 70 - 76. 10.9739/tjvs.2021.748
Chicago AKAY Tankut,Sade Leyla Elif,Savas Bozbas Serife,Hekimoglu Koray,okyay kaan,Gultekin Bahadir,BEYAZPINAR Deniz Sarp,GUNERTEM EREN,Aliyev Anar,Sezgin Atila How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . (2021): 70 - 76. 10.9739/tjvs.2021.748
MLA AKAY Tankut,Sade Leyla Elif,Savas Bozbas Serife,Hekimoglu Koray,okyay kaan,Gultekin Bahadir,BEYAZPINAR Deniz Sarp,GUNERTEM EREN,Aliyev Anar,Sezgin Atila How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . , 2021, ss.70 - 76. 10.9739/tjvs.2021.748
AMA AKAY T,Sade L,Savas Bozbas S,Hekimoglu K,okyay k,Gultekin B,BEYAZPINAR D,GUNERTEM E,Aliyev A,Sezgin A How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . . 2021; 70 - 76. 10.9739/tjvs.2021.748
Vancouver AKAY T,Sade L,Savas Bozbas S,Hekimoglu K,okyay k,Gultekin B,BEYAZPINAR D,GUNERTEM E,Aliyev A,Sezgin A How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . . 2021; 70 - 76. 10.9739/tjvs.2021.748
IEEE AKAY T,Sade L,Savas Bozbas S,Hekimoglu K,okyay k,Gultekin B,BEYAZPINAR D,GUNERTEM E,Aliyev A,Sezgin A "How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered ." , ss.70 - 76, 2021. 10.9739/tjvs.2021.748
ISNAD AKAY, Tankut vd. "How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered ". (2021), 70-76. https://doi.org/10.9739/tjvs.2021.748
APA AKAY T, Sade L, Savas Bozbas S, Hekimoglu K, okyay k, Gultekin B, BEYAZPINAR D, GUNERTEM E, Aliyev A, Sezgin A (2021). How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . Turkish journal of vascular surgery, 30(1), 70 - 76. 10.9739/tjvs.2021.748
Chicago AKAY Tankut,Sade Leyla Elif,Savas Bozbas Serife,Hekimoglu Koray,okyay kaan,Gultekin Bahadir,BEYAZPINAR Deniz Sarp,GUNERTEM EREN,Aliyev Anar,Sezgin Atila How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . Turkish journal of vascular surgery 30, no.1 (2021): 70 - 76. 10.9739/tjvs.2021.748
MLA AKAY Tankut,Sade Leyla Elif,Savas Bozbas Serife,Hekimoglu Koray,okyay kaan,Gultekin Bahadir,BEYAZPINAR Deniz Sarp,GUNERTEM EREN,Aliyev Anar,Sezgin Atila How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . Turkish journal of vascular surgery, vol.30, no.1, 2021, ss.70 - 76. 10.9739/tjvs.2021.748
AMA AKAY T,Sade L,Savas Bozbas S,Hekimoglu K,okyay k,Gultekin B,BEYAZPINAR D,GUNERTEM E,Aliyev A,Sezgin A How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . Turkish journal of vascular surgery. 2021; 30(1): 70 - 76. 10.9739/tjvs.2021.748
Vancouver AKAY T,Sade L,Savas Bozbas S,Hekimoglu K,okyay k,Gultekin B,BEYAZPINAR D,GUNERTEM E,Aliyev A,Sezgin A How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered . Turkish journal of vascular surgery. 2021; 30(1): 70 - 76. 10.9739/tjvs.2021.748
IEEE AKAY T,Sade L,Savas Bozbas S,Hekimoglu K,okyay k,Gultekin B,BEYAZPINAR D,GUNERTEM E,Aliyev A,Sezgin A "How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered ." Turkish journal of vascular surgery, 30, ss.70 - 76, 2021. 10.9739/tjvs.2021.748
ISNAD AKAY, Tankut vd. "How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: Too many gray zones to be considered ". Turkish journal of vascular surgery 30/1 (2021), 70-76. https://doi.org/10.9739/tjvs.2021.748